The two licensed bivalent and quadrivalent human papillomavirus (HPV) L1 (the major
papillomavirus virion protein) virus-like particle (VLP) vaccines are regarded as safe …

HPV infection with 'high-risk'genotypes is associated with ano-genital and oropharyngeal
cancers. Two currently licensed prophylactic HPV vaccines designed to prevent disease …

Despite the availability of prophylactic vaccines against human papillomavirus (HPV),
cervical cancer (CC) is still a major problem globally. It is the cancer with the second highest …

Human papillomavirus (HPV) types 16 and 18 account for approximately 70% of cervical
cancer worldwide. Neutralizing HPV prophylactic vaccines offer significant benefit, as they …

Recombinant strains of Lactococcus lactis NZ9000 that express native and codon-optimized
E6 protein (fused to the SPusp45 secretion signal) were successfully constructed by using …

Human papillomavirus (HPV) infections are a major human health problem; they are the
cause of recurrent benign warts and of several cancers of the anogenital tract and head and …

BACKGROUND: Serology for human papillomaviruses (HPV) types-16 and-18 is
established as an important tool for studies of HPV vaccinology and epidemiology. However …

In general, human pathogen-related small circular deoxyribonucleic acid (DNA) molecules
are bacterial plasmids and a group of viral genomes. Plasmids are extra-chromosomal small …

Background The goal of this study was to identify the nature of the inclusion bodies that have
been found in HeLa cells (cervical cancer immortal cell line) by electron microscope and to …

Abstract Background and Aims: Advances in the treatment of cervical cancer over the last
decade have predominantly involved the development of genes directed at molecular …